Page last updated: 2024-08-17

cytidine and valopicitabine

cytidine has been researched along with valopicitabine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amador, A; Benzaria, S; Bridges, EG; Cretton-Scott, E; D'Amours, M; Gosselin, G; Mao, J; Mathieu, S; Moussa, A; Pierra, C; Sommadossi, JP; Standring, DN; Storer, R1
Cammack, N; Chiu, S; Hu, S; Kang, H; Kosaka, A; Le Pogam, S; Nájera, I; Rajyaguru, S; Seshaadri, A; Symons, J1
Kronenberger, B; Zeuzem, S1
Boyer, SH; Carroll, SS; Erion, MD; Fujitaki, JM; Handt, L; Hecker, SJ; Koeplinger, K; Linemeyer, DL; MacCoss, M; Olsen, DB; Reddy, KR; Sun, Z; van Poelje, PD; Vavrek, M; Zhang, NR1

Reviews

1 review(s) available for cytidine and valopicitabine

ArticleYear
Future treatment options for HCV: double, triple, what is the optimal combination?
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Antiviral Agents; Cytidine; DNA-Directed RNA Polymerases; Drug Delivery Systems; Drug Resistance, Viral; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Oligopeptides; Polyethylene Glycols; Prodrugs; Proline; Protease Inhibitors; Pyrimidine Nucleosides; Recombinant Proteins; Ribavirin

2008

Other Studies

3 other study(ies) available for cytidine and valopicitabine

ArticleYear
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine.
    Journal of medicinal chemistry, 2006, Nov-02, Volume: 49, Issue:22

    Topics: Animals; Antiviral Agents; Biological Availability; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Cytidine; Cytosol; Hepacivirus; Humans; Liver; Magnetic Resonance Spectroscopy; Prodrugs; Protein Binding; Pyrimidine Nucleosides; Rats; Rats, Sprague-Dawley; Solubility

2006
Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Cytidine; Drug Resistance, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Pyrimidine Nucleosides; Sequence Analysis, DNA; Viral Nonstructural Proteins; Virus Replication

2008
Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzees.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Animals; Antiviral Agents; Cytidine; Cytidine Monophosphate; Female; Hepacivirus; Hepatitis C; Hepatocytes; Macaca mulatta; Male; Pan troglodytes; Prodrugs; Pyrimidine Nucleosides; Rats; Rats, Sprague-Dawley; Viral Load

2011